Cite
MLA Citation
Jia Li Low et al.. “Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia.” Therapeutic advances in medical oncology, vol. 14, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100169888349.0x00020a